These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 10715147)

  • 1. Design of potent dicyclic (4-10/5-8) gonadotropin releasing hormone (GnRH) antagonists.
    Rivier JE; Struthers RS; Porter J; Lahrichi SL; Jiang G; Cervini LA; Ibea M; Kirby DA; Koerber SC; Rivier CL
    J Med Chem; 2000 Mar; 43(5):784-96. PubMed ID: 10715147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design of monocyclic (1-3) and dicyclic (1-3/4-10) gonadotropin releasing hormone (GnRH) antagonists.
    Rivier JE; Porter J; Cervini LA; Lahrichi SL; Kirby DA; Struthers RS; Koerber SC; Rivier CL
    J Med Chem; 2000 Mar; 43(5):797-806. PubMed ID: 10715148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design of potent dicyclic (1-5/4-10) gonadotropin releasing hormone (GnRH) antagonists.
    Rivier JE; Jiang G; Struthers RS; Koerber SC; Porter J; Cervini LA; Kirby DA; Craig AG; Rivier CL
    J Med Chem; 2000 Mar; 43(5):807-18. PubMed ID: 10715149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Consensus bioactive conformation of cyclic GnRH antagonists defined by NMR and molecular modeling.
    Koerber SC; Rizo J; Struthers RS; Rivier JE
    J Med Chem; 2000 Mar; 43(5):819-28. PubMed ID: 10715150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conformational analysis of a highly potent dicyclic gonadotropin-releasing hormone antagonist by nuclear magnetic resonance and molecular dynamics.
    Bienstock RJ; Rizo J; Koerber SC; Rivier JE; Hagler AT; Gierasch LM
    J Med Chem; 1993 Oct; 36(22):3265-73. PubMed ID: 8230116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antagonist and agonist binding models of the human gonadotropin-releasing hormone receptor.
    Söderhäll JA; Polymeropoulos EE; Paulini K; Günther E; Kühne R
    Biochem Biophys Res Commun; 2005 Jul; 333(2):568-82. PubMed ID: 15950933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel sst(4)-selective somatostatin (SRIF) agonists. 1. Lead identification using a betide scan.
    Rivier J; Erchegyi J; Hoeger C; Miller C; Low W; Wenger S; Waser B; Schaer JC; Reubi JC
    J Med Chem; 2003 Dec; 46(26):5579-86. PubMed ID: 14667212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potent pituitary-gonadal axis suppression and extremely low anaphylactoid activity of a new gonadotropin releasing hormone (GnRH) receptor antagonist "azaline B".
    Campen CA; Lai MT; Kraft P; Kirchner T; Phillips A; Hahn DW; Rivier J
    Biochem Pharmacol; 1995 May; 49(9):1313-21. PubMed ID: 7763313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design of novel bicyclic analogues derived from a potent oxytocin antagonist.
    Flouret G; Chaloin O; Borovickova L; Slaninová J
    J Pept Sci; 2006 Jun; 12(6):412-9. PubMed ID: 16432806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Minimal-size, constrained corticotropin-releasing factor agonists with i-(i+3) Glu-Lys and Lys-Glu bridges.
    Rivier J; Lahrichi SL; Gulyas J; Erchegyi J; Koerber SC; Craig AG; Corrigan A; Rivier C; Vale W
    J Med Chem; 1998 Jul; 41(14):2614-20. PubMed ID: 9651165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel sst(4)-selective somatostatin (SRIF) agonists. 3. Analogues amenable to radiolabeling.
    Erchegyi J; Waser B; Schaer JC; Cescato R; Brazeau JF; Rivier J; Reubi JC
    J Med Chem; 2003 Dec; 46(26):5597-605. PubMed ID: 14667214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-function studies of linear and cyclized peptide antagonists of the GnRH receptor.
    Beckers T; Bernd M; Kutscher B; Kühne R; Hoffmann S; Reissmann T
    Biochem Biophys Res Commun; 2001 Dec; 289(3):653-63. PubMed ID: 11726197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Constrained corticotropin-releasing factor (CRF) agonists and antagonists with i-(i+3) Glu-Xaa-DXbb-Lys bridges.
    Koerber SC; Gulyas J; Lahrichi SL; Corrigan A; Craig AG; Rivier C; Vale W; Rivier J
    J Med Chem; 1998 Dec; 41(25):5002-11. PubMed ID: 9836618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design of biologically active, conformationally constrained GnRH antagonists.
    Struthers RS; Tanaka G; Koerber SC; Solmajer T; Baniak EL; Gierasch LM; Vale W; Rivier J; Hagler AT
    Proteins; 1990; 8(4):295-304. PubMed ID: 2091022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-activity relationships of the unique and potent agouti-related protein (AGRP)-melanocortin chimeric Tyr-c[beta-Asp-His-DPhe-Arg-Trp-Asn-Ala-Phe-Dpr]-Tyr-NH2 peptide template.
    Wilczynski A; Wilson KR; Scott JW; Edison AS; Haskell-Luevano C
    J Med Chem; 2005 Apr; 48(8):3060-75. PubMed ID: 15828845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design of potent cyclic gonadotropin releasing hormone antagonists.
    Rivier J; Kupryszewski G; Varga J; Porter J; Rivier C; Perrin M; Hagler A; Struthers S; Corrigan A; Vale W
    J Med Chem; 1988 Mar; 31(3):677-82. PubMed ID: 3279211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiovulatory antagonists of LHRH related to antide.
    Flouret G; Arnold ZS; Majewski T; Petousis NH; Mahan K; Farooqui F; Blum KA; Konopinska D; Natarajan S; Crich D
    J Pept Sci; 1995; 1(2):89-108. PubMed ID: 9222987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gonadotropin-releasing hormone antagonists: novel members of the azaline B family.
    Rivier JE; Jiang G; Porter J; Hoeger CA; Craig AG; Corrigan A; Vale W; Rivier CL
    J Med Chem; 1995 Jul; 38(14):2649-62. PubMed ID: 7629804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel sst(4)-selective somatostatin (SRIF) agonists. 2. Analogues with beta-methyl-3-(2-naphthyl)alanine substitutions at position 8.
    Erchegyi J; Penke B; Simon L; Michaelson S; Wenger S; Waser B; Cescato R; Schaer JC; Reubi JC; Rivier J
    J Med Chem; 2003 Dec; 46(26):5587-96. PubMed ID: 14667213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased histamine release by luteinizing hormone-releasing hormone antagonists obtained upon translocation of the cationic amino acid from position 8 to position 7.
    Flouret G; Mahan K; Majewski T
    J Med Chem; 1992 Feb; 35(4):636-40. PubMed ID: 1371810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.